These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1919939)

  • 21. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
    Xu GG; Luo CY; Wu SM; Wang CL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
    Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
    Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.
    Faber J; Hørslev-Petersen K; Perrild H; Lorenzen I
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1016-21. PubMed ID: 2401705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I and III procollagens in CAPD: markers of peritoneal fibrosis.
    Joffe P; Jensen LT
    Adv Perit Dial; 1991; 7():158-60. PubMed ID: 1680415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
    Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
    Zheng M; Cai WM; Weng HL; Liu RH
    World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum type I collagen propeptide and severity of alcoholic liver disease.
    Niemelä O; Blake JE; Orrego H
    Alcohol Clin Exp Res; 1992 Dec; 16(6):1064-7. PubMed ID: 1471760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
    Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
    Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
    Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
    Lin DY; Chu CM; Sheen IS; Liaw YF
    Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
    Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procollagen Type I C-terminal propeptide, procollagen Type III N-terminal propeptide, hyaluronic acid, and laminin in the cerebrospinal fluid of rats with communicating hydrocephalus.
    Xu H; Wang Z; Zhang S; Tan G; Zhu H
    J Neurosurg Pediatr; 2013 Jun; 11(6):692-6. PubMed ID: 23560698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C.
    Attallah AM; Toson EA; Shiha GE; Omran MM; Abdel-Aziz MM; El-Dosoky I
    J Immunoassay Immunochem; 2007; 28(3):199-211. PubMed ID: 17613667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic and renal extraction of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig.
    Bentsen KD; Henriksen JH; Boesby S; Hørslev-Petersen K; Lorenzen I
    J Hepatol; 1989 Sep; 9(2):177-83. PubMed ID: 2809157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type III and type I procollagen markers in fibrosing alveolitis.
    Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
    Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity.
    Lotterer E; Gressner AM; Kropf J; Grobe E; von Knebel D; Bircher J
    J Hepatol; 1992 Jan; 14(1):71-7. PubMed ID: 1737919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.